These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1140 related articles for article (PubMed ID: 20360050)
1. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology. Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050 [TBL] [Abstract][Full Text] [Related]
2. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease. Dickson TC; Saunders HL; Vickers JC Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714 [TBL] [Abstract][Full Text] [Related]
3. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Dickson TC; Vickers JC Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304 [TBL] [Abstract][Full Text] [Related]
4. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease. Nicoll JAR; Buckland GR; Harrison CH; Page A; Harris S; Love S; Neal JW; Holmes C; Boche D Brain; 2019 Jul; 142(7):2113-2126. PubMed ID: 31157360 [TBL] [Abstract][Full Text] [Related]
5. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488 [TBL] [Abstract][Full Text] [Related]
6. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology. Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991 [TBL] [Abstract][Full Text] [Related]
7. CD40 ligation mediates plaque-associated tau phosphorylation in beta-amyloid overproducing mice. Laporte V; Ait-Ghezala G; Volmar CH; Ganey C; Ganey N; Wood M; Mullan M Brain Res; 2008 Sep; 1231():132-42. PubMed ID: 18606155 [TBL] [Abstract][Full Text] [Related]
8. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574 [TBL] [Abstract][Full Text] [Related]
9. A Study of Amyloid-β and Phosphotau in Plaques and Neurons in the Hippocampus of Alzheimer's Disease Patients. Furcila D; DeFelipe J; Alonso-Nanclares L J Alzheimers Dis; 2018; 64(2):417-435. PubMed ID: 29914033 [TBL] [Abstract][Full Text] [Related]
11. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Su JH; Cummings BJ; Cotman CW Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927 [TBL] [Abstract][Full Text] [Related]
12. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation. Yilmazer-Hanke DM; Hanke J Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla). Perez SE; Raghanti MA; Hof PR; Kramer L; Ikonomovic MD; Lacor PN; Erwin JM; Sherwood CC; Mufson EJ J Comp Neurol; 2013 Dec; 521(18):4318-38. PubMed ID: 23881733 [TBL] [Abstract][Full Text] [Related]
14. Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain. Martin-Rehrmann MD; Hoe HS; Capuani EM; Rebeck GW Neurotox Res; 2005; 7(3):231-42. PubMed ID: 15897157 [TBL] [Abstract][Full Text] [Related]
15. Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease. Paquet C; Amin J; Mouton-Liger F; Nasser M; Love S; Gray F; Pickering RM; Nicoll JA; Holmes C; Hugon J; Boche D J Pathol; 2015 Apr; 235(5):721-30. PubMed ID: 25430817 [TBL] [Abstract][Full Text] [Related]
16. Active full-length DNA Aβ Rosenberg RN; Fu M; Lambracht-Washington D Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039 [TBL] [Abstract][Full Text] [Related]
17. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. Schmidt ML; DiDario AG; Lee VM; Trojanowski JQ FEBS Lett; 1994 May; 344(1):69-73. PubMed ID: 8181568 [TBL] [Abstract][Full Text] [Related]
18. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. Mrak RE; Sheng JG; Griffin WS J Neuropathol Exp Neurol; 1996 Mar; 55(3):273-9. PubMed ID: 8786385 [TBL] [Abstract][Full Text] [Related]
19. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain. Takahashi RH; Tobiume M; Sato Y; Sata T; Gouras GK; Takahashi H Neuropathology; 2011 Jun; 31(3):208-14. PubMed ID: 21062360 [TBL] [Abstract][Full Text] [Related]
20. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease. Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]